Since January, InCrowd has been conducting novel coronavirus (COVID-19) tracking research to understand the impact of the pandemic on several US healthcare stakeholder groups. Now in its fifth wave, InCrowd has been monitoring frontline-treating physicians’ perceptions on the spread of the virus, preparedness, a variety of concerns, and how they envision both pharma engagement and care delivery in the future. Discover the latest findings and insights from InCrowd’s most recent wave of COVID-19 physician research.
Methodology:
- Method: 12-minute MicroSurvey via InCrowd
- Crowds: US Primary Care Physicians (PCPs), Pediatricians (PEDs), and Emergency Medicine or Critical Care Physicians (EMCCs)
- Sample Size: n=211
- Fielding Period: June 26, 2020 (Previous Waves: May 29-31, Apr. 14-15, Mar. 19-20, Feb. 26-27, Jan. 31-Feb. 4)
InCrowd’s other COVID-19 Tracking Reports:
